Skip to main content
Explore URMC
menu
Blood Cancer Research Moves from Lab to Clinic with UR CTSI Help

Blood Cancer Research Moves from Lab to Clinic with UR CTSI Help

With the help of a UR CTSI Incubator Award, Wilmot Cancer Institute researcher Laura Calvi, M.D, has translated discoveries from the lab to a clinical trial that has begun to help patients with blood cancer. 

UR CTSI Pilot Study Identifies Memory “Fingerprints”

UR CTSI Pilot Study Identifies Memory “Fingerprints”

UR CTSI-supported researchers are the first to observe and quantify the differences between how people reimagine common scenarios. These unique neurological “fingerprints” could ultimately be used to understand, study and even improve the treatment of disorders such as Alzheimer’s disease.  

Past Pilot Awardee Granted $2M to Develop Better Statistics to Measure MicroRNA

Past Pilot Awardee Granted $2M to Develop Better Statistics to Measure MicroRNA

With his first R01, Matthew McCall, Ph.D., will continue research that was previously funded by the UR CTSI. He aims to develop statistical methods to measure expression levels of microRNAs, which impact many human diseases. 

2020 Pilot Awards: Predicting Alzheimer’s, Heart Failure, Understanding Intellectual Disabilities

2020 Pilot Awards: Predicting Alzheimer’s, Heart Failure, Understanding Intellectual Disabilities

In July, three new pilot awardees began their UR CTSI-funded projects. Over the next year, the awardees will dissect the cellular and molecular causes of intellectual disabilities and develop new ways to predict Alzheimer's disease in seniors and heart failure in patients who need left ventricular assist devices (LVAD).

Just a Drop of Blood: An Easier Way to Test for COVID-19

Just a Drop of Blood: An Easier Way to Test for COVID-19

UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous flu research to develop a potential diagnostic test that would require just a few drops of blood to detect COVID-19 immunity.

123